1. Korean Institute for Health and Social Affairs. Prevalence of asthma like symptoms in Korean adult population. Korean J Med. 2001; 60:196–205.
3. Barnes PJ. New drugs for asthma. Semin Respir Crit Care Med. 2012; 33:685–694.
![crossref](/image/icon/bnr_ref_cross.gif)
4. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000; 343:332–336.
![crossref](/image/icon/bnr_ref_cross.gif)
5. Global Initiative for Asthma. Global strategy for the diagnosis and prevention [Internet]. Global Initiative for Asthma;2017. cited 2017 Dec 29. Available from:
https://ginasthma.org/.
6. Kim DK, Park YB, Oh YM, Jung KS, Yoo JH, Yoo KH, et al. Korean asthma guideline 2014: summary of major updates to the Korean asthma guideline 2014. Tuberc Respir Dis. 2016; 79:111–120.
![crossref](/image/icon/bnr_ref_cross.gif)
7. Brode SK, Campitelli MA, Kwong JC, Lu H, Marchand-Austin A, Gershon AS, et al. The risk of mycobacterial infections associated with inhaled corticosteroid use. Eur Respir J. 2017; 50:1700037.
![crossref](/image/icon/bnr_ref_cross.gif)
8. Lee CH, Kim K, Hyun MK, Jang EJ, Lee NR, Yim JJ. Use of inhaled corticosteroids and the risk of tuberculosis. Thorax. 2013; 68:1105–1113.
![crossref](/image/icon/bnr_ref_cross.gif)
9. Qian CJ, Coulombe J, Suissa S, Ernst P. Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study. Br J Clin Pharmacol. 2017; 83:2077–2086.
![crossref](/image/icon/bnr_ref_cross.gif)
10. Smeeth L, Boulis M, Hubbard R, Fletcher AE. A population based case-control study of cataract and inhaled corticosteroids. Br J Ophthalmol. 2003; 87:1247–1251.
![crossref](/image/icon/bnr_ref_cross.gif)
11. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol. 1995; 96(5 Pt 1):571–579.
![crossref](/image/icon/bnr_ref_cross.gif)
12. Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: effects on growth. Cochrane Database Syst Rev. 2014; (7):CD009471.
![crossref](/image/icon/bnr_ref_cross.gif)
13. van Noord JA, Smeets JJ, Maesen FP. A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction. Respir Med. 1998; 92:1346–1351.
![crossref](/image/icon/bnr_ref_cross.gif)
14. Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet. 1989; 1:917–922.
![crossref](/image/icon/bnr_ref_cross.gif)
15. Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockroft D, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med. 1994; 149(3 Pt 1):604–610.
![crossref](/image/icon/bnr_ref_cross.gif)
16. Suissa S, Hemmelgarn B, Blais L, Ernst P. Bronchodilators and acute cardiac death. Am J Respir Crit Care Med. 1996; 154(6 Pt 1):1598–1602.
![crossref](/image/icon/bnr_ref_cross.gif)
17. O'Byrne PM, Jenkins C, Bateman ED. The paradoxes of asthma management: time for a new approach? Eur Respir J. 2017; 50:1701103.
18. Beasley R, Weatherall M, Shirtcliffe P, Hancox R, Reddel HK. Combination corticosteroid/beta-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma? J Allergy Clin Immunol. 2014; 133:39–41.